Net Income (Loss) Attributable to Noncontrolling Interest

Name: BridgeBio Pharma Net Income (Loss) Attributable to Noncontrolling Interest by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BridgeBio Pharma·Business Segments·1 segment·Rolls up to Net Income (NCI)

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$2.19M	-$1.77M	-$2.51M
Total	—	—	—

Segments

Business SegmentsView metric